Journal
JOURNAL OF DRUG TARGETING
Volume 25, Issue 1, Pages 41-48Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/1061186X.2016.1184668
Keywords
FAK; glioblastoma; metastasis; naringin; proliferation
Categories
Ask authors/readers for more resources
As the most common and lethal primary malignant brain cancer, glioblastoma is hard to timely diagnose and sensitive therapeutic monitoring. It is essential to develop new and effective drugs for glioblastoma multiform. Naringin belongs to citrus flavonoids and was found to display strong anti-inflammatory, antioxidant and antitumor activities. In this report, we found that naringin can specifically inhibit the kinase activity of FAK and suppress the FAK(p-Try397)and its downstream pathway in glioblastoma cells. Our study showed out that naringin can inhibit cell proliferation by inhibiting FAK/cyclin D1 pathway, promote cell apoptosis through influencing FAK/bads pathway, at the same time, it can also inhibit cell invasion and metastasis by inhibiting the FAK/mmps pathway. All these showed that naringin exerts the anti-tumor effects in U87MG by inhibiting the kinase activity of FAK.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available